Novan

About:

Novan is a clinical-stage drug development company developing deliverable nitric oxide.

Website: https://novan.com/

Twitter/X: novan_biotech

Top Investors: Ligand Pharmaceuticals, U.S. Department of Defense, Malin Corporation, Aspire Capital Partners LLC

Description:

Novan develops products that tap the anti-bacterial properties of nitric oxide by encapsulating the compound in nano-particles that deliver therapeutic agents to desired body location. They use its proprietary nitric oxide-based science and technology platform to develop innovative, first-in-class therapies for unmet medical needs. The company is committed to using the power of the human body to create safe and effective treatments. They complement their internal scientific talent with strategic partners around the globe to enable Novan to harness the power of nitric oxide and develop technologies that will help address currently untreated and under-treated medical conditions. It was incorporated in 2008 and is based in Morrisville, North Carolina.